Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: Apr 23, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
Shuttle Pharma filed an 8-K, no major news yet.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on April 23, 2024, reporting other events and financial statements. The filing does not contain specific details about new events or financial figures, but serves as a notification to the SEC.
Why It Matters
This filing indicates Shuttle Pharmaceuticals is providing updates or required disclosures to the SEC, which could be routine or signal significant corporate events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific material disclosures, suggesting routine reporting.
Key Numbers
- 001-41488 — SEC File Number (Identifies the company's filing with the SEC.)
- 82-5089826 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- April 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported, only that this item is included.
Are there any new financial statements or exhibits attached to this filing?
The filing indicates 'Financial Statements and Exhibits' as an item, but the content of these documents is not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 23, 2024.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the company's state of incorporation?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware.
Filing Stats: 963 words · 4 min read · ~3 pages · Grade level 12.6 · Accepted 2024-04-23 16:36:23
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 12KB
- 0001493152-24-015703.txt ( ) — 232KB
- shph-20240423.xsd (EX-101.SCH) — 3KB
- shph-20240423_lab.xml (EX-101.LAB) — 33KB
- shph-20240423_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: April 23, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer